CAMBRIDGE, Mass.--(BUSINESS WIRE)--April 20, 2006--EPIX Pharmaceuticals, Inc. (Nasdaq:EPIX - News), a developer of innovative pharmaceuticals for magnetic resonance imaging (MRI), today announced that it will release first quarter 2006 financial results on Monday, May 1, 2006, before the open of regular market trading hours. A conference call to discuss these results and provide an update on clinical, regulatory and business activities, as well as the pending merger with Predix Pharmaceuticals, is scheduled for later that day, Monday, May 1, 2006, at 10:30 a.m. Eastern Time.
